BTG Bio-Tropin preliminary injunction upheld; growth hormone launch must await trial against Genentech.
Executive Summary
BIO-TECHNOLOGY GENERAL BIO-TROPIN PRELIMINARY INJUNCTION UPHELD by Washington, D.C. federal appellate court April 8. The ruling prevents the company from selling its human growth hormone product, approved in May, until completion of the patent infringement trial with Genentech. The trial is not expected to begin until next year.